We investigated the role of the beta-3-adrenergic receptor polymorphism in
membrane lipid composition and erythrocyte membrane sodium transport in ess
ential hypertensive patients. We studied 87 essential hypertensive patients
determining: The Trp64Arg mutation of the beta-3-adrenergic receptor by PC
R, lipoprotein profile by standard laboratory methods, membrane lipid compo
sition by LATROSCAN and erythrocyte sodium lithium countertransport by Cane
ssa technique. Patients with the mutation as compared with those without it
showed lower membrane cholesterol, membrane cholesterol phospholipids rati
o and erythrocyte sodium lithium countertransport, however blood pressure a
nd the other studied variables were similar in both groups of patients. Aft
er adjusting by sex sodium lithium countertransport activity remained signi
ficant. These data suggest that although the Trp64Arg mutation of the beta-
3-adrenergic receptor is related with a different membrane lipid compositio
n and erythrocyte sodium lithium countertransport values it does not contri
bute to blood pressure levels in essential hypertensive patients. (C) 2000
Elsevier Science Inc. All rights reserved.